Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank23
3Y CAGR-40.1%
5Y CAGR-28.5%
Year-over-Year Change
Quality of reported income
3Y CAGR
-40.1%/yr
vs +9.5%/yr prior
5Y CAGR
-28.5%/yr
Recent deceleration
Acceleration
-49.7pp
Decelerating
Percentile
P23
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.20 | +100.0% |
| 2024 | -1092.71 | -105991.3% |
| 2023 | 1.03 | +12.8% |
| 2022 | 0.91 | +996.9% |
| 2021 | -0.10 | -109.7% |
| 2020 | 1.05 | -3.5% |
| 2019 | 1.09 | +71.4% |
| 2018 | 0.64 | -24.8% |
| 2017 | 0.84 | +276.2% |
| 2016 | -0.48 | - |